PMGC Holdings ELAB
NASDAQ ELAB
$3.54 -0.09 (-2.48%)
At close: Sep 30, 2026 · 4:00 PM EDT

PMGC Holdings (ELAB) Operating Interest Expenses (2025)

Updated

PMGC Holdings (ELAB) reported Operating Interest Expenses of $179,479 for Q3 2025.

Analysis

PMGC Holdings (ELAB) Operating Interest Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Interest Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 PMGC Holdings 1.73 Mn -46.63 Mn 385,691.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 179,479.00
API Access

PMGC Holdings Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-interest-expenses&ticker=ELAB&period=max&api_key=YOUR_API_KEY